Caricamento...
In-silico drug repurposing for targeting SARS-CoV-2 main protease (M(pro))
COVID-19, caused by novel coronavirus or SARS-CoV-2, is a viral disease which has infected millions worldwide. Considering the urgent need of the drug for fighting against this infectious disease, we have performed in-silico drug repurposing followed by molecular dynamics (MD) simulation and MM-GBSA...
Salvato in:
| Pubblicato in: | J Biomol Struct Dyn |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678360/ https://ncbi.nlm.nih.gov/pubmed/33179568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1844058 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|